The Effect of the Mediterranean Diet on Gut Microbiota and Its Impact on Neurodegenerative Diseases: A Narrative Review

Farzaneh Rafie Sedaghat,1,2,* Somayeh Ahmadi,1,2,* Tina Samadpour Zahmat-dar,1 Samira Saedi,2 Hossein Samadi Kafil3 1Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran; 2Department of Bacteriology and Virology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran; 3Drug Applied Research Center, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran*These authors contributed equally to this workCorrespondence: Hossein Samadi Kafil, Email [email protected]: Due to their complex etiology and the intricacy of brain systems, neurodegenerative diseases (NDs), which progressively deteriorate neural tissue, remain difficult to treat. The gut-brain axis emphasizes the host–gut microbiota (GM) interaction and offers a new perspective on these diseases. In Alzheimer’s disease (AD), there is a hypothesis of the migration of amyloid-β oligomers from the gut to the brain may affect neuroinflammation. Also, in Parkinson’s disease (PD), GM in the gastrointestinal mucosal layer may misfold and accumulate α-synuclein, leading to its transfer to the brain. Multiple Sclerosis (MS) is affected by GM that influences immune responses toward inflammation through modulation of T-helper cell polarization, T-regulatory (T-reg) cell function, and B-cell activity. Furthermore, neuromyelitis optica spectrum disorder (NMOSD) is linked to antibodies that target the astrocyte-expressed water channel protein aquaporin-4 (AQP4) and may be related to GM and needs more research. Diet is a major factor that could modulate GM composition. The Mediterranean Diet (MD) is anti-inflammatory, antioxidant, and gut-modulating due to its high vegetable, fruit, whole grain, and olive oil intake. It boosts beneficial GM and their byproducts, which suppresses inflammation and may slowing progression and improve PD, AD, MS, and NMOSD, influencing disease progression and symptoms. This review aims to investigate the interaction between GM composition and the MD and how they jointly influence neurodegenerative diseases such as AD, PD, MS, and NMOSD.Keywords: alzheimer disease, parkinson disease, multiple sclerosis, neuro myelitis optica spectrum disease, gut microbiota, Mediterranean diet

Authors

Publication Details

Journal
Dove Medical Press (Taylor and Francis Group)
Published
2026-02-17
Primary Topic
Gut microbiota and health
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Effect of the Mediterranean Diet on Gut Microbiota and Its Impact on Neurodegenerative Diseases: A Narrative Review

Samira Saedi, Somayeh Ahmadi, Farzaneh Rafie Sedaghat, Hossein Samadi Kafil et al.
Dove Medical Press (Taylor and Francis Group)
Gut microbiota and health
article

The Effect of the Mediterranean Diet on Gut Microbiota and Its Impact on Neurodegenerative Diseases: A Narrative Review

Samira Saedi, Somayeh Ahmadi, Farzaneh Rafie Sedaghat, Hossein Samadi Kafil, Tina Samadpour Zahmat-dar
article en

Abstract

Farzaneh Rafie Sedaghat,1,2,* Somayeh Ahmadi,1,2,* Tina Samadpour Zahmat-dar,1 Samira Saedi,2 Hossein Samadi Kafil3 1Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran; 2Department of Bacteriology and Virology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran; 3Drug Applied Research Center, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran*These authors contributed equally to this workCorrespondence: Hossein Samadi Kafil, Email [email protected]: Due to their complex etiology and the intricacy of brain systems, neurodegenerative diseases (NDs), which progressively deteriorate neural tissue, remain difficult to treat. The gut-brain axis emphasizes the host–gut microbiota (GM) interaction and offers a new perspective on these diseases. In Alzheimer’s disease (AD), there is a hypothesis of the migration of amyloid-β oligomers from the gut to the brain may affect neuroinflammation. Also, in Parkinson’s disease (PD), GM in the gastrointestinal mucosal layer may misfold and accumulate α-synuclein, leading to its transfer to the brain. Multiple Sclerosis (MS) is affected by GM that influences immune responses toward inflammation through modulation of T-helper cell polarization, T-regulatory (T-reg) cell function, and B-cell activity. Furthermore, neuromyelitis optica spectrum disorder (NMOSD) is linked to antibodies that target the astrocyte-expressed water channel protein aquaporin-4 (AQP4) and may be related to GM and needs more research. Diet is a major factor that could modulate GM composition. The Mediterranean Diet (MD) is anti-inflammatory, antioxidant, and gut-modulating due to its high vegetable, fruit, whole grain, and olive oil intake. It boosts beneficial GM and their byproducts, which suppresses inflammation and may slowing progression and improve PD, AD, MS, and NMOSD, influencing disease progression and symptoms. This review aims to investigate the interaction between GM composition and the MD and how they jointly influence neurodegenerative diseases such as AD, PD, MS, and NMOSD.Keywords: alzheimer disease, parkinson disease, multiple sclerosis, neuro myelitis optica spectrum disease, gut microbiota, Mediterranean diet

Dove Medical Press (Taylor and Francis Group)
Openalex Percentile: Top 52%
Gut microbiota and health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

The Effect of the Mediterranean Diet on Gut Microbiota and Its Impact on Neurodegenerative Diseases: A Narrative Review — Samira Saedi, Somayeh Ahmadi, et al. · Dove Medical Press (Taylor and Francis Group) (2026) | TGRS Research Map | TGRS